← Evidence map

ArticleAnnals of the rheumatic diseases2023

Efficacy and safety of emapalumab in macrophage activation syndrome.

Fabrizio De Benedetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

82 papers cite itlatest 60 shown

2023
…
2024
2025
2026
this paperpooled itcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 37001971